SLN - Silence Therapeutics plc

QQQ $ 451.63 $ -0.22 (-0.05 %)

DIA $ 399.76 $ 0.74 (0.19 %)

SPY $ 529.24 $ 0.76 (0.14 %)

TLT $ 91.40 $ -0.62 (-0.67 %)

GLD $ 223.63 $ 3.63 (1.65 %)

Previous Close

$ 23

Open

$ 23.39

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 22.78 - $ 23.62

52 Week Range

$ 4.84 - $ 27.72

Volume

121,162

Average Volume

Market Cap

2.73B

Beta (5Y Monthly)

$ 1.07

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on Sile...
05/17/2024 17:40:53

HC Wainwright & Co. analyst Patrick Trucchio reiterates Silence Therapeutics (NASDAQ:SLN) with a Buy and maintains $75 p...

What 7 Analyst Ratings Have To Say About S...
05/17/2024 13:01:00

Chardan Capital Maintains Buy on Silence T...
05/17/2024 12:50:28

Chardan Capital analyst Keay Nakae maintains Silence Therapeutics (NASDAQ:SLN) with a Buy and maintains $42 price target.

Silence Therapeutics Q1 Collaboration Reve...
05/16/2024 12:42:39

Beyond The Numbers: 7 Analysts Discuss Sil...
04/22/2024 18:00:53

Morgan Stanley Maintains Overweight on Sil...
04/22/2024 17:29:59

Morgan Stanley analyst Michael Ulz maintains Silence Therapeutics (NASDAQ:SLN) with a Overweight and maintains $45 price tar...

Silence Therapeutics Announces JAMA Public...
04/08/2024 15:49:21

Silence Therapeutics plc, Nasdaq: SLN ("Silence" or the "Company"), an experienced and innovative biotechnology...

HC Wainwright & Co. Reiterates Buy on Sile...
03/15/2024 16:57:20

HC Wainwright & Co. analyst Patrick Trucchio reiterates Silence Therapeutics (NASDAQ:SLN) with a Buy and maintains $75 p...

these-analysts-boost-their-forecasts-on-silence-therapeutics-after-full-year-2023-results

These Analysts Boost Their Forecasts On Si...
03/14/2024 18:01:29

Silence Therapeutics Plc (NASDAQ: SLN) reported a loss for 2023 on Wednesday.

Morgan Stanley Maintains Overweight on Sil...
03/14/2024 16:33:40

Morgan Stanley analyst Michael Ulz maintains Silence Therapeutics (NASDAQ:SLN) with a Overweight and raises the price target...

Chardan Capital Maintains Buy on Silence T...
03/14/2024 11:54:52

Chardan Capital analyst Keay Nakae maintains Silence Therapeutics (NASDAQ:SLN) with a Buy and raises the price target from $...

What 4 Analyst Ratings Have To Say About S...
03/13/2024 20:01:18

HC Wainwright & Co. Maintains Buy on Silen...
03/13/2024 15:34:02

HC Wainwright & Co. analyst Patrick Trucchio maintains Silence Therapeutics (NASDAQ:SLN) with a Buy and maintains $75 pr...

whats-going-on-with-silence-therapeutics-stock-today

What's Going On With Silence Therapeutics ...
03/13/2024 14:16:29

Silence Therapeutics reports narrower Q4 loss, data from zerlasiran study, and strengthened cash position. In March 2024, Malli...

Silence Therapeutics Reported 2023 Revenue...
03/13/2024 11:09:15

Financial Highlights for Year End 2023 Cash Position: Cash and cash equivalents of £54.0 million ($68.8 million) as of Decem...

Silence Therapeutics Announces Topline 36-...
03/13/2024 11:01:42

Silence Therapeutics plc, Nasdaq: SLN ("Silence" or the "Company"), an experienced and innovative biotechnology...

Earnings Scheduled For March 13, 2024
03/13/2024 10:15:56

Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share...

Earnings Scheduled For March 12, 2024
03/12/2024 09:35:47

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter.

Silence Therapeutics Achieves $10M Milesto...
02/23/2024 13:05:07

Silence Therapeutics plc, Nasdaq: SLN ("Silence" or "the Company"), an experienced and innovative biotechnology...

HC Wainwright & Co. Reiterates Buy on Sile...
02/22/2024 14:04:02

HC Wainwright & Co. analyst Patrick Trucchio reiterates Silence Therapeutics (NASDAQ:SLN) with a Buy and maintains $75 p...